Calcification Resistance With Aluminum-Ethanol Treated Porcine Aortic Valve Bioprostheses in Juvenile Sheep
|
|
- Shannon Harmon
- 5 years ago
- Views:
Transcription
1 Calcification Resistance With Aluminum-Ethanol Treated Porcine Aortic Valve Bioprostheses in Juvenile Sheep Matthew F. Ogle, MS, Sheila J. Kelly, BS, Richard W. Bianco, BS, and Robert J. Levy, MD Heart Valve Division, St. Jude Medical Inc, St. Paul, Minnesota, Department of Experimental Surgery, University of Minnesota, Minneapolis, Minnesota, and Division of Cardiology, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania Background. Calcification of glutaraldehyde fixed bioprosthetic heart valve replacements frequently leads to the clinical failure of these devices. Previous research by our group has demonstrated that ethanol pretreatment prevents bioprosthetic cusp calcification, but not aortic wall calcification. We have also shown that aluminum chloride pretreatment prevents bioprosthetic aortic wall calcification. This study evaluated the combined use of aluminum and ethanol to prevent both bioprosthetic porcine aortic valve cusp and aortic wall calcification in rat subcutaneous implants, and the juvenile sheep mitral valve replacement model. Methods. Glutaraldehyde fixed cusps and aortic wall samples were pretreated sequentially first with aluminum chloride (AlCl 3 ) followed by ethanol pretreatment. These samples were then implanted subdermally in rats with explants at 21 and 63 days. Stent mounted bioprostheses were prepared either sequentially as previously described or differentially with AlCl 3 exposure restricted to the aortic wall followed by ethanol pretreatment. Mitral valve replacements were carried out in juvenile sheep with elective retrievals at 90 days. Results. Rat subdermal explants demonstrated that sequential exposure to AlCl 3 and ethanol completely inhibited bioprosthetic cusp and aortic wall calcification compared with controls. However the sheep results were markedly different. The differential sheep explant group exhibited very low levels of cusp and wall calcium. The glutaraldehyde group exhibited little cusp calcification, but prominent aortic wall calcification. All sheep in the two groups previously described lived to term without evidence of valvular dysfunction. In contrast, animals in the sequential group exhibited increased levels of cusp calcification. None of the animals in this group survived to term. Pathologic analysis of the valves in the sequential group determined that valve failure was caused by calcification and stenosis of the aortic cusps. Conclusions. The results clearly demonstrate that a combination of aluminum and ethanol reduced aortic wall calcification and prevented cuspal calcification. Furthermore, this study demonstrates that exclusion of aluminum from the cusp eliminated the cuspal calcification seen when aluminum and ethanol treatments were administered in a sequential manner. (Ann Thorac Surg 2003;75: ) 2003 by The Society of Thoracic Surgeons Stentless bioprosthetic tissue heart valves have become recognized as an important therapeutic option in the surgical treatment of heart valve disease [1 3]. However, clinically available xenografts [1, 2] are at risk to undergo dystrophic calcification of the aortic wall. This calcification may affect the long-term function of these devices and the outcome of reoperation. Previous studies [3, 4] have demonstrated that ethanol pretreatment inhibits calcification of pretreated glutaraldehyde porcine aortic valve cusps. The mechanism of ethanol inhibition of dystrophic calcification is believed to be the action of ethanol extracting lipids and altering collagen structure of the bioprosthetic material [5, 6]. However, ethanol pretreatment of bioprosthetic valve constructs has little to no inhibitory effect on aortic wall Accepted for publication Sept 16, Address reprint requests to Dr Levy, Children s Hospital of Philadelphia, Abramson Pediatric Research Center, Suite 702, 3516 Civic Center Blvd, Philadelphia, PA 19104; levyr@ .chop.edu. calcification [7]. Aluminum chloride (AlCl 3 ) pretreatment has been demonstrated to inhibit aortic wall calcification [8, 9]. The mechanisms of this inhibition are related to prevention of elastin calcification and reduction of regional alkaline phosphatase activity [10, 11]. In the present study we investigated the combined pretreatment of ethanol and aluminum chloride for the prevention of both cuspal and aortic wall mineralization in porcine aortic valve bioprosthetic implants. Furthermore, prior research by our group [12] and the research of others [13] suggested that AlCl 3 cusp exposure could actually exacerbate leaflet calcification in the blood stream, but not in subdermal implants. Thus we hypothesized that the combined use of ethanol and AlCl 3 could Doctors Ogle and Kelly disclose that they have a financial relationship with St. Jude Medical, Inc, St. Paul, MN by The Society of Thoracic Surgeons /03/$30.00 Published by Elsevier Science Inc PII S (02)
2 1268 OGLE ET AL Ann Thorac Surg ALUMINUM TREATED VALVES IN SHEEP 2003;75: inhibit both bioprosthetic cusp and aortic wall calcification. However, rat subdermal implants may not reveal evidence of an adverse cuspal outcome because of the AlCl 3. Therefore we sought to compare rat subdermal and sheep circulatory model system results. To this end we systematically developed novel pretreatment conditions for the combined use of ethanol and AlCl 3, including the sequential treatment of the entire bioprosthetic valve(alcl 3 first, then ethanol) compared with a differential exposure (AlCl 3 exposed only to the aortic wall). Assessment of inhibition of bioprosthetic calcification was the key endpoint of interest in these studies. Material and Methods In Vitro Aluminum Deposition Porcine aortic valves were dissected and the cusp tissue fixed with buffered (0.5%) glutaraldehyde. Three sample groups were created. Group I contained six control cusps with no aluminum treatment. Group II contained six cusps incubated for 2 hours in 0.1 mol/l aluminum chloride hexahydrate, ph 7.4 (Sigma Chemical Co, St. Louis, MO). Group III contained six cusps incubated for 2 hours in 0.1 mol/l aluminum chloride hexahydrate, ph 3 (Sigma Chemical Co, St. Louis, MO). All sets of samples were rinsed once in 10 ml of HEPES (0.05 mol/l, ph 7.4) buffered saline. Samples were then bisected, and one half of each specimen was processed for histology and stained for aluminum using aluminum stain (Histoserv, Inc, Gatherburg MD), and the other half of each specimen was analyzed using inductively coupled plasmaatomic emission spectroscopy (ICP-AES) (Thermal Jarrell Ash, Franklin, MA). Implant Tissue Preparation Three groups of glutaraldehyde fixed (low pressure fixation, 2 to 4mm Hg) bioprosthetic valves were prepared. Group I consisted of glutaraldehyde fixed porcine aortic valves as previously described [14]. Group II consisted of glutaraldehyde fixed porcine aortic valves subjected to sequential aluminum and ethanol treatment; specifically these valves were first incubated in a ph 3 aluminum chloride solution (0.1 mol/l), then in a buffered (0.05 mol/l HEPES, ph 7.4) ethanol solution (80%). Group III consisted of glutaraldehyde fixed porcine aortic valves subjected to differential aluminum and ethanol treatment; specifically these valve walls were treated exclusively with aluminum chloride (0.1 mol/l) followed by a total valve incubation in a buffered ethanol solution (80%). A process was developed by using the fact that aluminum in solution is a weak acid, and when aluminum is adjusted to ph 7 it precipitates as aluminum hydroxide. While the root tissue is incubated in aluminum solution, the cusps are bathed with a ph 7.0 buffered solution which prevents association of aluminum with the valve cusps. All valves in all groups were fabricated on a prototype stent for sheep implants or were dissected for subcutaneous rat implants. Rat Study Rat studies were performed in compliance with the animal care committee guidelines for small animal operations. Three-week-old, male Sprague Dawley rats were used. They received a preoperative injection of ketamine hydrochloride 85 mg/kg by intraperitoneal injection. Samples in each treatment group were color-coded with surgical suture before implant. An incision was made in the back of each rat and six samples, randomly selected from each of three treatment groups (previously described) were implanted into individual subcutaneous pockets. At the termination of the study (21 and 63 days) animals were euthanized with intraperitoneal injection of Beuthanasia solution (Schering Plough, Union, NJ), 86 mg/kg mixed 1:1 with normal saline. Explanted samples were placed in 0.9% saline for storage before analysis. Each tissue sample was removed from the saline and sectioned in half. One half of the tissue sample was cleaned of host tissue and used for elemental analysis. The second half of the tissue was placed in 10% neutral buffered formalin and stored for histologic examination. Sheep Study Animal acquisition and preoperative and postoperative evaluations were conducted using protocols previously described [3]. Briefly, 18 sheep (Ovis aries), of either gender and between ages 3 and 5 months were used. An operation was performed under general anesthesia with cardiopulmonary bypass as previously published [3]. All animals were cared for at Experimental Surgery Services, University of Minnesota (Minneapolis, MN), an American Association of Laboratory Animal Care (AALAC) accredited facility. Serum studies were performed preoperatively and immediately before sacrifice at 90 days. The gross pathology was performed at Experimental Surgery Services. Under general anesthesia, the chest was entered through a fourth intercostal incision. The heart was entered through the left atrium. The leaflets of the native mitral valve (including the entire chordae apparatus) were removed and the bioprosthetic valve was placed in the mitral annulus. The valve was sutured with interrupted 3-0 braided polyester sutures in an inverted mattress pattern. All animals received broad-spectrum antibiotic prophylaxis, analgesia, and diuretics. Animals surviving less than 48 hours postoperatively were considered technical failures and were not included in the study. Only interoperative deaths were excluded from the result analysis. Early deaths that appeared to be related to calcific stenosis were included. Animals surviving more than 48 hours, but dying before the scheduled 90 day study period, were autopsied using the study protocol, and were included in all analyses. The animals were euthanized at 90 days, and total autopsy including evaluation of the brain, lungs, liver, spleen, and kidneys was performed. Macroscopic evaluation and photography of the heart and bioprosthetic valve was performed before fixation in 10% neutral buffered formalin. Portions of all organs were submitted
3 Ann Thorac Surg OGLE ET AL 2003;75: ALUMINUM TREATED VALVES IN SHEEP 1269 for paraffin embedding. Animal care complied with the Principles of Laboratory Animal Care and the Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No , 1985). Photographs were made of each excised valve and surrounding tissue. A radiograph of each excised valve was made at 65 kv for 30 seconds. The valve was then removed from the stenting material. One section of each valve leaflet and supporting aortic wall tissue was submitted for histologic preparation at American HistoLabs, Inc (Gaithersburg, MD). Another section of each leaflet with wall tissue was submitted for elemental analysis at St. Jude Medical, Inc. Histology The degree and character of the general architectural features and the extent of inflammation were evaluated using the hematoxylin-eosin stain. The aluminum associated with the tissue was evaluated with aluminum stain. The degree of calcification was evaluated using the von Kossa stain. The character and extent of the fibrous healing response and the extent of fibrin accumulation was evaluated using the Movat s Pentachrome stain. A calcification grading scale was developed and applied in a blinded manner to all specimens with 0 no calcium staining identifiable, 1 rare granules of calcification, 2 nodular collections of calcium less than 25% surface area, 3 extensive collections of calcium 25% to 50%, and 4 near total calcification more than 50%. Elemental Analysis Explanted valve (cusp and aortic wall) tissue sections were cleaned of host tissue and washed with saline followed by distilled water, and then lyophilized and weighed. Each tissue sample was hydrolyzed in nitric acid and diluted to a standard volume. Elemental analysis was performed using inductively coupled plasmaatomic emission spectroscopy. Elemental concentrations of calcium and phosphorus were reported in mg per gram of dry tissue. Statistical Analysis One way analysis of variance was used to determine statistical significance between the results of each test group, cusp, and aortic wall. Subsequent differences were evaluated using either the Bonferroni or Tukey posthoc analysis. Linear regression was used to determine a correlation between rat and sheep study ICP-AES results and to determine a correlation between the sheep ICP-AES results and the histologic scale. Results In Vitro Aluminum Deposition This brief study sought to investigate the maximum loading potential of aluminum into bioprosthetic tissue for both acidic ( ph 3) and physiologic (ph 7.4) conditions. These experiments were necessary in order to establish the optimal incubation conditions for AlCl 3 Fig 1. Elemental analysis of cusp tissue after incubation with aluminum chloride solution. Note the high aluminum incorporation levels at acidic ph compared with those at physiologic ph that were barely detectable. Untreated control cusp and aortic wall were below the limits of detection (0.12 ppm). pretreatment of bioprostheses, and to assess aluminum loading levels with respect to potential systemic exposure. The results indicate that very little aluminum (0.13 mg/g in the cusps) was associated with the tissue under physiologic conditions (Fig 1). The limited aluminum association at ph 7.4 is likely due to the relative insolubility of aluminum salts at physiologic ph [15]. Under the acidic incubation conditions there was significantly more aluminum associated with the bioprosthetic tissue (7.56 mg/g aluminum). Histology results using aluminum staining to detect aluminum deposition (Fig 2) demonstrates a diffuse deposition of aluminum in the tissue primarily in or around cell membranes and structural proteins. In Vivo Rat Evaluation Both cusp and aortic wall samples treated sequentially with the combination of aluminum and ethanol demonstrated significant reduction in calcification versus the glutaraldehyde control, which demonstrated severe calcification of both wall and cusp tissue (Table 1). Furthermore, the host response to these aluminum and ethanol treated samples showed no additional inflammation or abnormal healing when compared with the glutaraldehyde-fixed control implants. In Vivo Sheep Explant Evaluation The calcification of all valves was evaluated by both a histopathologic grading scale and elemental analysis (Figs 3, 4). Groups I (glutaraldehyde control) and III (differential ethanol and AlCl 3 ) experienced no mortality or adverse valvular events for the 90-day duration of the study (Fig 5). However, group II (sequential ethanol and AlCl 3 ) experienced 100% mortality by 45 days, caused by dystrophic calcification of the bioprosthetic valve cusps. The control group I exhibited low cuspal calcification, but high levels of aortic wall calcification. The differential group III exhibited significantly lower levels of both cusp and wall calcification (p 0.001). In contrast, the sequen-
4 1270 OGLE ET AL Ann Thorac Surg ALUMINUM TREATED VALVES IN SHEEP 2003;75: Fig 3. Ninety-day sheep study calcium histopathologic grading. See Methods for conditions used for group I (control), group II (sequential AlCl 3 and ethanol), and group III (differential AlCl 3 and ethanol). Note grading for groups I and III were zero for cusp tissue, and thus no bar graphs are shown. Fig 2. Representative histomicrographs of cusp tissue (stained with aluminum stain 100) incubated in either 0.1 mol/l aluminum chloride at ph 3 (A) or at ph 7.4 (B). tial group II exhibited a statistically significant increase in cuspal calcification (p 0.001). Histopathologic examination of the valves from the 90-day sheep study found that the greatest degree of calcification was in the control group I, followed by the sequential ethanol and aluminum treated group 2. Calcification of the control valves (group I) was localized primarily in the aortic wall (Fig 4). Calcification of sequentially treated valves (group II) was found in both cusp and wall tissue. For all study groups, inflammation was limited to the interface between the valve and host tissue. Radiographs and histomicrographs provided additional information regarding the distribution of calcium throughout the bioprosthetic tissue (Fig 6). Severe aortic wall calcification was seen in group I. The low level of wall calcification seen in group II was limited to the cusp and wall interface at the line of leaflet attachment. No calcification was seen in group III, which received the differential ethanol and AlCl 3 pretreatment. There was a correlation noted between the actual calcium content of both cusps and aortic wall determined by ICP-AES and the histologic scale used to assess the extent of calcification, r (cusp) and r 0.941(aortic wall). In all groups no significant differences were observed between hematologic and blood chemistry profiles preoperatively and at termination. For all groups, no abnormal pathologic findings were observed in any of the organ samples. Comment This study showed that a combination of ethanol and AlCl 3 can be used to effectively prevent both aortic cusp and wall calcification. The novel approach of excluding aluminum from the cusp tissue using a buffer system eliminated the severe cuspal calcification seen in our sheep studies when ethanol and AlCl 3 were used sequentially. These results differed significantly from our Table 1. Rat Study Calcium Content (mg per Gram of Dry Tissue) TEST Group Cusp Aortic Wall 21 days 63 Days 21 Days 63 Days Pre-implant NA NA Glutaraldehyde controls (group I) Aluminum/ethanol sequential (group II) For the study sample size, n 10. NA not available.
5 Ann Thorac Surg OGLE ET AL 2003;75: ALUMINUM TREATED VALVES IN SHEEP 1271 Fig 4. Ninety-day sheep study calcium content (mg/g of dry tissue). See Methods for description of group I (control), group II (sequential AlCl 3 and ethanol), and group III (differential AlCl 3 and ethanol). Note preimplant levels and all cusp values except Group II were barely detectable. sequentially prepared rat subdermal implants that did not demonstrate cusp calcification associated with AlCl 3 pretreatment. Other research by our group [12] has demonstrated that this effect is most likely caused by the very low affinity of aluminum binding to cuspal structural proteins compared with high affinity binding to the elastin enriched aortic wall extracellular matrix; the net result of this is dissociation of cuspal aluminum with circulatory washout of loosely bound aluminum leading to aluminum precipitates with carbonate or phosphate, or both, and subsequent mineral deposition. It is widely accepted that stentless aortic valves have better hydrodynamic characteristics compared with their stented counterparts and more closely approximate the native hemodynamic characteristics of the aortic valves [15 17]. The advantage appears in part to relate to the maintained compliance of the prosthetic tissue [18]. Although low pressure fixation is often used to prepare bioprosthesis, Fig 5. Ninety-day sheep study percent survival. See Methods for pretreatments used in group I (control), group II (sequential AlCl 3 and ethanol), and group III (differential AlCl 3 and ethanol). Note group I and group III lines are coincident. there is no evidence this helps to prevent bioprosthetic calcification. Thus currently available stentless valves still undergo mineralization [19 21]. Mineralization may affect the long-term function of these devices, to the point where surgical replacement of the valve is necessary. To address this problem, several groups have proposed anticalcification pretreatments [22 24]. These methodologies appear to inhibit bioprosthetic cusp calcification. To date, none of these treatments have been shown to be effective in preventing aortic wall calcification, thus underlining the importance of the findings described here. It should be noted that although our model systems evaluated bioprosthetic cusp and aortic wall calcification in a stent mounted configuration, AlCl 3 inhibition of aortic wall calcification has been demonstrated in nonstented glutaraldehyde-fixed allografts in circulatory implants [25], thus providing further validation of the observed efficacy for preventing aortic wall calcification in the present studies. Furthermore the technical difficulty of placing a stentless bioprostheses in the aortic position in the juvenile sheep precludes a calcification study with a directly comparable clinical configuration. The anticalcific effects of aluminum and other metal cations on bioprosthetic tissue has been the subject of a number of studies over the past 10 years [8 11]. The mechanism of ethanol inhibition of cuspal calcification has been investigated in a number of studies that have demonstrated prevention of mineralization due to alterations in collagen structure and extraction of cuspal lipids [3 7]. Pretreatment with ethanol is now used clinically on St. Jude Medical (St. Paul, MN) bioprosthetic heart valves as an anticalcification treatment. Until now, the ability to combine the beneficial effects of ethanol and AlCl 3 pre treatments in a functioning preclinical model has not been reported. However, our group observed that incubation of cuspal tissue with aluminum chloride induced accelerated calcification. Aortic wall tissue did not calcify significantly compared with controls under similar conditions. There is no obvious explanation for the accelerated cuspal calcification observed in the sequential group in the sheep model. It is highly likely that this is due to some aspect of AlCl 3 exposure, because previous studies have shown that ethanol pretreatment significantly inhibits cuspal calcification, both in subdermal implants and in circulatory experiments [3] Ongoing experiments indicate that although AlCl 3 pretreatment of elastin, a major component of aortic wall, results in irreversible binding of aluminum, comparable AlCl 3 incubations of type I collagen, the most abundant collagen in porcine cusps, results in unstable binding of aluminum [12]. Thus, the leaching of Al 3 ions from collagen binding sites into the cuspal interstitium could lead to microprecipitates. Aluminum phosphate or carbonate microprecipitates could hypothetically damage the bioprosthetic cusps directly, or the formation of aluminum carbonates or phosphates could provide a nidus for dystrophic calcification. Furthermore, since rat subdermal implants demonstrated inhibition of cuspal calcification with sequential ethanol and AlCl 3 exposure, it can be concluded
6 1272 OGLE ET AL Ann Thorac Surg ALUMINUM TREATED VALVES IN SHEEP 2003;75: Fig 6. Roentgenogram analysis and histomicrographs showing calcium distribution in bioprosthetic sheep explants. (A) Group I (control) radiograph. (B) Group I aortic wall (Von Kossa stain, original magnification 100). (C) Group I aortic cusp (Von Kossa stain, original magnification 200). (D) Group II (sequential AlCl 3 and ethanol) radiograph. (E) Group II aortic wall (Von Kossa stain, original magnification 100). (F) Group II aortic cusp (Von Kossa stain, original magnification 200). (G) Group III (differential AlCl 3 and ethanol) roentgenogram. (H) Group III aortic wall (Von Kossa stain, original magnification 100) (I) Group III aortic cusp (Von Kossa stain, original magnification 200). that some aspect of blood material interactions may be of mechanistic importance in the cuspal calcification in the sequential group. Both ethanol and AlCl 3 pretreatments have been studied individually with demonstrated efficacy for inhibiting calcification of bioprosthetic aortic cusp [4] and the aortic wall [25], respectively, in circulatory implants. Thus the present study investigated the combined use of these pretreatments. We have demonstrated a decrease in calcification of the differentially treated tissues compared with sequential treatment in the sheep model. Of note, calcification of the differentially treated valve cusps was not significantly different than the control valve cusps, neither calcified, possibly because of the short duration of the study (90 days). A prior time course study by our group has shown that 90-day mitral valve bioprosthetic replacements in juvenile sheep have minimal cuspal calcification [26]. Nevertheless, we chose this time point to evaluate both the potential for exacerbated calcification, and the combined beneficial effects of ethanol and AlCl 3 on aortic wall calcification. The next step in the evaluation of the differential aluminum and ethanol treatment will be to
7 Ann Thorac Surg OGLE ET AL 2003;75: ALUMINUM TREATED VALVES IN SHEEP 1273 extend the duration of the study to 150 days to confirm the benefits of this treatment on cuspal tissue. In conclusion, ethanol and AlCl 3 can be used in combination to effectively inhibit both bioprosthetic cuspal and aortic wall calcification in this sheep model. We have shown the importance of a differential pretreatment approach, restricting AlCl 3 from the aortic valve cusps in order to prevent AlCl 3 -related cuspal mineralization. Sequential pretreatment with ethanol and AlCl 3 had a deleterious effect leading to cuspal calcification, but nevertheless resulted in inhibition of aortic wall mineralization. The authors thank Jennifer LeBold for her assistance with manuscript preparation. Research support was provided by St. Jude Medical Inc. Doctor Levy s efforts were supported in part by the National Heart, Lung, and Blood Institute grant HL38118 and by The William J. Rashkind Endowment of the Children s Hospital of Philadelphia. References 1. Schoen FJ, Kujovich JL, Levy RJ, St. John Sutton M. Bioprosthetic valve failure. Cardiovas Clin 1988;18: Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 1994;90: Vyavahare, N, Hirsch, D, Lerner, et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Circulation1997;95: Langanki D, Ogle MF, Cameron JD, Lirtzman RA, Schroeder RF, Mirsch MW. Evaluation of a novel bioprosthetic heart valve incorporating anticalcification and antimicrobial technology in a sheep model. J Heart Valve Dis 1998;7: Vyavahare NR, Jones PL, Hirsch D, Schoen FJ, Levy RJ. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. J Heart Valve Dis 2000;9: Vyavahare NR, Hirsch D, Lerner E, et al. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res 1998;40: Lee CH, Vyavahare N, Zand R, et al. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res 1998;42: Webb CL, Flowers WE, Boyd J, Rosenthal EL, Schoen FJ, Levy RJ. Al binding studies, and metallic cation effects on bioprosthetic heart valve. Calcification in the rat subdermal model. ASAIO 1990;36: Webb CL, Nguyen NM, Schoen FJ, Levy RJ. Calcification of allograft aortic wall in a rat subdermal model. Am J Pathol 1992;141: Levy RJ, Schoen FJ, Flowers WB, Staelin ST. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations. J Biomed Mater Res 1991;25: Vyavahare N, Ogle M, Schoen FJ, Levy RJ. Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol 1999;155: Levy, RJ, Vyavahare, N, Ogle, M, Ashworth, P, Bianco, R, Schoen, FJ. Inhibition of cups and aortic wall calcification in ethanol and aluminum treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. J Heart Valve Dis. In press, Carpentier SM, Carpentier AF, Chen L, Shen M, Quintero LJ, Witzel TH. Calcium mitigation in bioprosthetic tissues by iron pretreatment: the challenge of iron leaching. Ann Thorac Surg 1995;60:S Goldman BS, David TE, Del Rizzo DF, Sever J, Bos J. Stentless porcine bioprosthesis for aortic valve replacement. J Cardiovasc Surg 1994;35: McQuarrie, DA, Rock PA. Solubility and precipitation reactions. General Chemistry. New York: W H Freeman and Company, 1987: Sung HW, Le TN, Kingsbury CJ, Quintero LJ, Myeres KE, Quijano RC. In vitro pulsatile flow evlauation of a stentless porcine aortic bioprosthesis. ASAIO J 1995;41: Eberhart CE, Yoganathan AP, Capps M, Toomes C. Hydrodynamic performance of the Medtronic freestyle aortic root bioprosthetic. In: Piwnica A, Westaby S, eds. Stentless Bioprostheses, Oxford, UK, ISIS Media, 1995: Konertz W, Herrmann M, Knauth M, Stabenow I, David T. Preliminary experience with the Toronto SPV stentless porcine bioprosthesis for aortic valve replacement. Thorac Cardiovasc Surg 1994;42: Herijgers P, Ozaki S, Verbeken E, et al. Calcification characteristics of porcine stentless valves in juvenile sheep. Eur J Cardiothorac Surg 1999;15: Dittrich S, Alexi-Meskishvili VV, Yankah AC. Comparison of porcine xenografts and homografts for pulmonary valve replacement in children. Ann Thorac Surg 2000;70: Sundt TM 3rd, Rasmi N, Wong K, Radley-Smith R, Khaghani A, Yacoub MH. Reoperative aortic valve operation after homograft root replacement: surgical options and results. Ann Thorac Surg 1995;60:S Herijgers P, Ozaki S, Verbeken E, et al. The No-React anticalcification treatment: a comparison of Biocor No-React II and Toronto SPV stentless bioprostheses implanted in sheep. Semin Thorac Cardiovasc Surg 1999;11: Chen W, Kim JD, Schoen FJ, Levy RJ. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves. J Biomed Mater Res 1994;28: Hirsch D, Drader J, Thomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies. J Biomed Mater Res 1993;27: Levy RJ, Qu X, Underwood T, Trachy J, Schoen FJ. Calcification of valved aortic allografts in rats: effects of age, crosslinking, and inhibitors. J Biomed Mater Res 1995;29: Schoen FJ, Hirsch D, Bianco RW, Levy RJ. Onset and progression of calcification in porcine aortic bioprosthetic mitral valve replacements in juvenile sheep. J Thorac Cardiovasc Surg 1994;108:880 7.
Aldehyde reduction in a novel pericardial tissue reduces calcification using rabbit intramuscular model
J Mater Sci: Mater Med (2017) 28:16 DOI 10.1007/s10856-016-5829-8 CLINICAL APPLICATIONS OF BIOMATERIALS Original Research Aldehyde reduction in a novel pericardial tissue reduces calcification using rabbit
More informationSynergistic Inhibition of Calcification of Porcine Aortic Root with Preincubation in FeCl 3 and a-amino Oleic Acid in a Rat Subdermal Model
Synergistic Inhibition of Calcification of Porcine Aortic Root with Preincubation in FeCl 3 and a-amino Oleic Acid in a Rat Subdermal Model Weiliam Chen, 1 Frederick J. Schoen, 2 David J. Myers, 3 Robert
More informationTrifecta Valve. Clinical Compendium. Five Year Data
Trifecta Valve Clinical Compendium Five Year Data Trifecta Valve Compendium INTRODUCTION The Trifecta valve is a tri-leaflet stented pericardial valve designed for supra-annular placement in the aortic
More informationResearch Article Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice CT Scanning
International Biomaterials Volume 2013, Article ID 617329, 7 pages http://dx.doi.org/10.1155/2013/617329 Research Article Evolving Bioprosthetic Tissue Calcification Can Be Quantified Using Serial Multislice
More informationAnti-calcifying Treatment of Glutaraldehyde Fixed Bovine Pericardium: Comparisons and Evaluation of Possible Synergic Effects
QCVC Committees Scientific Activities Central Hall General Information FAC Thematic Units Arrhythmias and Electrophysiology Basic Research Bioengineering and Medical Informatics Cardiac Surgical Intensive
More informationLate failure of transcatheter heart valves: An open question
Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement
More informationRe-do aortic valve replacement after previous homograft aortic root replacement
Re-do aortic valve replacement after previous homograft aortic root replacement Jullien Gaer, Toufan Bahrami, Fabio de Robertis, Ahmed Abdulsalam, John Pepper, NHS Foundation Trust, UK Professor Sir Magdi
More informationHemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves
Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Speaker's name: I have the following potential conflicts of interest to report: Proctorship for Medtronic Agenda Failure modes
More informationEight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis
Eight-Year Results of Aortic Root Replacement With the Freestyle Stentless Porcine Aortic Root Bioprosthesis Neal D. Kon, MD,* Robert D. Riley, MD, Sandy M. Adair, RN, Dalane W. Kitzman, MD, and A. Robert
More informationThe increasing number of elderly patients with complex
Valved Stentless Composite Graft: Clinical Outcomes and Hemodynamic Characteristics Paul P. Urbanski, MD, Anno Diegeler, MD, Alexander Siebel, MD, Michael Zacher, MD, and Robert W. Hacker, MD Herz- und
More informationDegeneration and Cacfi cation of Bioprosthetic Cardiac Valves
ANIMAL MODEL OF HUMAN DISEASE Degeneration and Cacfi cation of Bioprosthetic Cardiac Valves Bioprosthetic Tricuspid Valve Implantation in Sheep GLENN R. BARNHART, MD, MICHAEL JONES, MD, TOKUHIRO ISHIHARA,
More informationI will not discuss off label use or investigational use in my presentation.
I will not discuss off label use or investigational use in my presentation. Surgical valves Design and Durability Testing Potential Concerns Real Practice 1952-1962 1963-1966 1967-1969 1969-1977 1977-1984
More informationCarpentier-Edwards ThermaFix Process: A Method for Extracting Calcium Binding Sites from Pericardial Tissue
Carpentier-Edwards ThermaFix Process: A Method for Extracting Calcium Binding Sites from Pericardial Tissue Jeffrey S. Dove, Principal Engineer Myron Howanec, Principal Engineer Mano J. Thubrikar, PhD,
More informationCoreValve in a Degenerative Surgical Valve
CoreValve in a Degenerative Surgical Valve Ran Kornowski, MD, FESC, FACC Chairman Department of Cardiology Rabin Medical Center, Petach Tikva, Israel Disclosure Statement of Financial Interest I, Ran Kornowski,
More informationCalcified Aortic Sinotubular Ridge: A Source of Coronary Ostial Stenosis or Embolism
1510 JACC Vol. 12, No, 6 December 1988:1510--4 Calcified Aortic Sinotubular Ridge: A Source of Coronary Ostial Stenosis or Embolism KEVIN J. TVETER, MD, JESSE E. EDWARDS, MD, FACC St, Paul, Minnesota This
More informationCalcification of Bovine Pericardium: Glutaraldehyde Versus No-React Biomodification
Calcification of Bovine Pericardium: Glutaraldehyde Versus No-React Biomodification Amir Abolhoda, MD, Sumei Yu, MS, J. Rodrigo Oyarzun, MD, John R. McCormick, MD, John D. Bogden, PhD, and Shlomo Gabbay,
More informationPATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT. Tissue Valve for Aortic and Mitral Valve Replacement
PATIENT BOOKLET MEDTRONIC SURGICAL VALVE REPLACEMENT Tissue Valve for Aortic and Mitral Valve Replacement ARE MEDTRONIC SURGICAL TISSUE HEART VALVES RIGHT FOR YOU? Medtronic surgical heart valves are for
More informationComposite stentless valve with graft extension for combined replacement of the aortic valve, root and ascending aorta
European Journal of Cardio-thoracic Surgery 20 (2001) 252±256 www.elsevier.com/locate/ejcts Composite stentless valve with graft extension for combined replacement of the aortic valve, root and ascending
More informationPast, Present and Future Early Innovations, Current Practice and Future Developments in Cardiac Valve Design and Technique
University of Minnesota Department of Surgery Presents The Second Annual Bakken Surgical Device Symposium Cardiac Valves: Past, Present and Future Early Innovations, Current Practice and Future Developments
More informationPrimary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: Hancock I Vekus Carpentier-Edwards at 4- to 7-Years Follow-up
Primary Tissue Valve Degeneration in Glutaraldehvde-Preserved Porcine Biomostheses: A Hancock I Vekus Edwards at 4- to 7-Years Follow-up Francisco Nistal, M.D., Edurne Artifiano, M.D., and Ignacio Gallo,
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationThe St. Jude Medical Biocor Bioprosthesis
The St. Jude Medical Biocor Bioprosthesis Clinical Evidence of Long-term Durability Long-term Biocor Experience A Review and Comparative Assessment Long-term Biocor Stented Tissue Valve Studies Twenty-year
More informationDegenerative aortic valve (AV) stenosis is the most
Crimping May Affect the Durability of Transcatheter Valves: An Experimental Analysis ADULT CARDIAC Philipp Kiefer, MD, Felix Gruenwald, Joerg Kempfert, MD, Heike Aupperle, PhD, Joerg Seeburger, MD, Friedrich
More informationA 20-year experience of 1712 patients with the Biocor porcine bioprosthesis
Acquired Cardiovascular Disease Mykén and Bech-Hansen A 2-year experience of 1712 patients with the Biocor porcine bioprosthesis Pia S. U. Mykén, MD, PhD, a and Odd Bech-Hansen, MD, PhD b Objective: The
More informationOnset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep
Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep The purpose of this study was to characterize the onset
More informationPrevention of calcification in bioprosthetic heart valves: challenges and perspectives
Review 1. Introduction 2. Current status and presentation of bioprosthetic heart valves 3. Macroscopic alterations in explanted bioprosthetic heart valves 4. Factors that influence bioprosthetic heart
More informationHeart valve substitutes are of two principal types:
Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention Frederick J. Schoen, MD, PhD, and Robert J. Levy, MD Department of Pathology, Brigham and Women s Hospital
More informationIn Vitro Two-Dimensional Echocardiographic Imaging of a Stented Porcine Bioprosthetic Valve: The Bent Strut Artifact
C 2008, the Author Journal compilation C 2008, Wiley Periodicals, Inc. DOI: 10.1111/j.1540-8175.2008.00753.x In Vitro Two-Dimensional Echocardiographic Imaging of a Stented Porcine Bioprosthetic Valve:
More informationTSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD
TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)
More information15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses
ORIGINAL CONTRIBUTION 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses WR Eric Jamieson, MD, Eva Germann, MSc, Michel R Aupart, MD 1, Paul H Neville, MD 1, Michel A Marchand,
More informationPPM: How to fit a big valve in a small heart
PPM: How to fit a big valve in a small heart Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC King Abdulaziz Cardiac Centre National Guard Health Affairs Riyadh, Saudi Arabia GHA meeting Muscat
More informationPorcine bioprosthesis use for surgical treatment of
Fifteen-Year Clinical Experience With the Biocor Porcine Bioprostheses in the Mitral Position Kaan Kırali, MD, Mustafa Güler, MD, Altuğ Tuncer, MD, Bahadır Dağlar, MD, Gökhan İpek, MD, Ömer Işık, MD, and
More informationStentless aortic valves. Current aspects
Endorsed by proceedings in Intensive Care Cardiovascular Anesthesia EXPERT OPINION HSR Proceedings in Intensive Care and Cardiovascular Anesthesia 2012; 4(2): 77-82 Stentless aortic valves. Current aspects
More information25 different brand names >44 different models Sizes mm
Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single
More informationPosterior leaflet prolapse is the most common lesion seen
Techniques for Repairing Posterior Leaflet Prolapse of the Mitral Valve Robin Varghese, MD, MS, and David H. Adams, MD Posterior leaflet prolapse is the most common lesion seen in degenerative mitral valve
More informationTAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology
TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for
More informationOutcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease
Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve
More informationThe stentless bioprosthesis has many salient features that
Aortic Valve Replacement with the Medtronic Freestyle Xenograft Using the Subcoronary Implantation Technique D. Michael Deeb, MD The stentless bioprosthesis has many salient features that make it an attractive
More informationStainless Steel. Cobalt-chromium
Sapien is better than Corevalve! Raj R. Makkar, MD Associate Director, Cedars-Sinai Heart Institute Associate Professor, UCLA School of Medicine, Los Angeles Eberhard Grube: Pioneer in the field of TAVR
More informationPulmonary Valve Replacement
Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of
More informationCarpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience
SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member
More informationAfter implanting more than 1500 heart valves in sheep over the years, Factors influencing calcification of cardiac bioprostheses in adolescent sheep
Factors influencing calcification of cardiac bioprostheses in adolescent sheep Willem Flameng, MD, PhD, a Bart Meuris, MD, a Jessa Yperman, a Geofrey De Visscher, PhD, a Paul Herijgers, MD, PhD, a and
More informationImages in Cardiovascular Medicine
Images in Cardiovascular Medicine Constrictive Pericarditis Presenting as a Large Mediastinal Mass Causing Functional Tricuspid and Pulmonary Stenosis Niklas F. Ehl, MD; Simon Sündermann, MD; Reinhard
More informationIncidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves
INTERVENTION/VALVULAR HEART DISEASE ORIGINAL ARTICLE Cardiology Journal 2016, Vol. 23, No. 2, 178 183 DOI: 10.5603/CJ.a2016.0011 Copyright 2016 Via Medica ISSN 1897 5593 Incidence of prosthesis-patient
More informationIndications and Late Results of Aortic Valve Repair
Indications and Late Results of Aortic Valve Repair Prof. Gebrine El Khoury Department of Cardiovascular and Thoracic Surgery Cliniques St. Luc Brussels, Belgium Aortic Valve Repair Question # 1 Can the
More informationEvolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa
Evolution of prosthetic heart valves L. Henry Edmunds, Jr, MD Philadelphia, Pa Charles Hufnagel developed and successfully implanted the first prosthetic cardiac valve in the descending thoracic aorta
More informationReconstruction of the intervalvular fibrous body during aortic and
Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,
More informationCROWN PRT. Inservice implantation guide
Inservice implantation guide DEVICE DESCRIPTION The Crown PRT aortic pericardial heart valve consists of a single piece of bovine pericardium that is preserved with glutaraldehyde and sewn onto a polyester
More informationThe growing sheep model has been used extensively
Behavior of Mitral Allografts in the Tricuspid Position in the Growing Sheep Model José M. Bernal, MD, José M. Rabasa, MD, Juan C. Cagigas, MD, Fernando Val, MD, and José M. Revuelta, MD Departments of
More informationAutologous Pulmonary Valve Replacement of the Diseased Aortic Valve
Autologous Pulmonary Valve Replacement of the Diseased Aortic Valve By L. GONZALEZ-LAvIN, M.D., M. GEENS. M.D., J. SOMERVILLE, M.D., M.R.C.P., ANm D. N. Ross, M.B., CH.B., F.R.C.S. SUMMARY Living tissue
More informationCLINICAL COMMUNIQUE 16 YEAR RESULTS
CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced
More informationCalcification of Porcine Aortic Valvular Interstitial Cells
Calcification of Porcine Aortic Valvular Interstitial Cells Liwen Gu 1,2* Supervisor: Craig A. Simmons 1 Department of Engineering Science, 2 Institute of Biomaterials and Biomedical Engineering, University
More informationDisease of the aortic valve is frequently associated with
Stentless Aortic Bioprosthesis for Disease of the Aortic Valve, Root and Ascending Aorta John R. Doty, MD, and Donald B. Doty, MD Disease of the aortic valve is frequently associated with morphologic abnormalities
More informationThe pulmonary valve is the most common heart valve
Biologic versus Mechanical Valve Replacement of the Pulmonary Valve After Multiple Reconstructions of the RVOT Tract S. Adil Husain, MD, and John Brown, MD Indiana University School of Medicine, Department
More informationEffect of Immunological Differences on Rat Aortic Valve Allograft Calcification
Effect of Immunological Differences on Rat Aortic Valve Allograft Calcification FLAVIAN M, LUPINETTI, M.D., * SANDRA COBB, B.S., * HANS C. KIOSCHOS, B.S.,* SUE ANN THOMPSON, PH.D.,* * KATHERINE S. WALTERS,
More informationBrief Communication. Alkaline Phosphatase Activity of Glutaraldehyde-Treated Bovine Pericardium Used in Bioprosthetic Cardiac Valves
844 Brief Communication Alkaline Phosphatase Activity of Glutaraldehyde-Treated Bovine Pericardium Used in Bioprosthetic Cardiac Valves Anthony R. Maranto and Frederick J. Schoen Bioprosthetic valves fail
More informationDecellularization of Aortic Homografts: South American and European Current Experience
Department of Cardiac Surgery Instituto de Neurologia e Cardiologia de Curitiba (INC-Cardio) Decellularization of Aortic Homografts: South American and European Current Experience Francisco Diniz Affonso
More informationP have been used for mitral and aortic valve replacement
A -Year Comparison of Mitral Valve Replacement With Carpentier-Edwards and Hancock Porcine Bioprostheses P. Perier, MD, A. Deloche, MD, S. Chauvaud, MD, J. C. Chachques, MD, J. Relland, MD, J. N. Fabiani,
More informationUNDERSTANDING YOUR HEART VALVE. Mosaic Tissue Valve
UNDERSTANDING YOUR HEART VALVE Mosaic Tissue Valve A Message to You from the Employees at Medtronic, Inc. We understand that having heart valve replacement surgery is an important change in your life.
More informationTranscatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,
Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Oslo, Norway Aortic regurgitation Prevalence in Framingham
More informationINTRODUCTION. Received 4 April 1997; accepted 22 August 1997
Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: Mechanistic studies of protein structure and water biomaterial relationships Narendra R. Vyavahare,
More informationAortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients
Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years experience in 130 patients Augusto D Onofrio, MD, Stefano Auriemma, MD, Paolo Magagna, MD, Alessandro Favaro, MD,
More information16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900
CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical
More information2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD
2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD David L Saint M.D. Tallahassee Memorial Hospital Southern Medical Group Division of Cardiothoracic
More information14 Valvular Stenosis
14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a
More informationRepeated mitral valve replacement in a patient with extensive annular calcification
CASE REPORT Open Access Repeated mitral valve replacement in a patient with extensive annular calcification Tadashi Kitamura 1,2*, Sachito Fukuda 1, Takahiro Sawada 1, Sumio Miura 1, Ikutaro Kigawa 1,3
More informationPROVEN PLUS. Introducing the Avalus Aortic Valve by Medtronic.
PROVEN PLUS. Introducing the Avalus Aortic Valve by Medtronic. With more than 40 years of heart valve innovations, we took proven valve design concepts and adapted them for excellent implantability for
More informationRelation of Calcification to Tom Leaflets
Relation of Calcification to Tom Leaflets of Spontaneously Degenerated Porcine Bioprosthetic Valves Paul D. Stein, M.D., Stephen R. Kemp, Ph.D., Jeanne M. Riddle, Ph.D., Min W. Lee, M.D., Joseph W. Lewis,
More informationMedtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance
Medtronic Mosaic porcine bioprosthesis: Assessment of 12-year performance W. R. Eric Jamieson, MD, a Friedrich-Christian Riess, MD, b Peter J. Raudkivi, MD, c Jacques Metras, MD, d Edward F. G. Busse,
More informationEXPERIMENTAL PLEURAL EMPYEMA PATHOLOGIC CHANGES
Trakia Journal of Sciences, Vol. 3, No. 2, pp 61-65, 2005 Copyright 2005 Trakia University Available online at: http://www.uni-sz.bg ISSN 1312-1723 Original Contribution EXPERIMENTAL PLEURAL EMPYEMA PATHOLOGIC
More informationHypoplasia of the aortic root1 The problem of aortic valve replacement
Hypoplasia of the aortic root1 The problem of aortic valve replacement ROWAN NICKS, T. CARTMILL, and L. BERNSTEIN Department of Cardio-thoracic Surgery and the Hallstrom Institute of Cardiology, the Royal
More informationCarpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years
Surgery for Acquired Cardiovascular Disease Carpentier-Edwards supra-annular aortic porcine bioprosthesis: Clinical performance over 20 years W. R. Eric Jamieson, MD, Lawrence H. Burr, MD, Robert T. Miyagishima,
More informationMorphometry of Mitral Valve in South Indians - A Cadaveric Study 1 2
Original Article Morphometry of Mitral Valve in South Indians - A Cadaveric Study Ilankathir.S, Sulochana Sakthivel ABSTRACT Aim: Mitral valve is a complex structure and understanding the normal anatomy
More informationExpanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?
Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,
More informationEleven years experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate
European Journal of Cardio-thoracic Surgery 22 (2002) 912 921 www.elsevier.com/locate/ejcts Eleven years experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with
More informationCorMatrix ECM Bioscaffold
CorMatrix ECM Bioscaffold REMODEL. REGROW. RESTORE. CorMatrix ECM Bioscaffold provides a natural bioscaffold matrix that enables the body s own cells to repair and remodel damaged cardio-vascular tissue.
More informationStentless full root bioprosthesis in surgery for complex aortic valve-ascending aortic disease: a single center experience of over 300 patients
European Journal of Cardio-thoracic Surgery 33 (2008) 554 559 www.elsevier.com/locate/ejcts Stentless full root bioprosthesis in surgery for complex aortic valve-ascending aortic disease: a single center
More informationManagement of Difficult Aortic Root, Old and New solutions
Management of Difficult Aortic Root, Old and New solutions Hani K. Najm MD, Msc, FRCSC,, FACC, FESC Chairman, Pediatric and Congenital Heart Surgery Cleveland Clinic Conflict of Interest None Difficult
More informationFor unclear reasons, only about 40% of patients with calcific aortic stenosis also have coronary
Αθηροσκλήρωση και ασβεστοποιός στένωση της αορτικής βαλβίδας. Οµοιότητες και διαφορές Ν. Μεζίλης Κλινική «Άγιος Λουκάς» Ασβεστοποιός στένωση της αορτικής βαλβίδας: Μία ακόµα µορφή αθηρωµάτωσης; Some observations
More informationA Loeys-Dietz Patient with a Trans-Atlantic Odyssey. Repeated Aortic Root Surgery ending with a Huge Left Main Coronary Aneurysm 4
1 2 3 A Loeys-Dietz Patient with a Trans-Atlantic Odyssey Repeated Aortic Root Surgery ending with a Huge Left Main Coronary Aneurysm 4 5 6 7 8 9 Thierry Carrel 1, Florian Schoenhoff 1 and Duke Cameron
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Vincelj, J., Sokol, I., Pevec, D., Sutlić, Ž. (2007) Infective endocarditis of aortic valve during pregnancy: A case report. International Journal of Cardiology, [Epub ahead
More informationPortico (St. Jude Medical Inc, St.
Review Article Portico Transcatheter Heart Valve Apostolos Tzikas 1,2, Michael Chrissoheris 2, Antonios Halapas 2, Konstantinos Spargias 2 1 Interbalkan European Medical Centre, Thessaloniki, 2 Hygeia
More informationTissue Reaction to Root Canal Filling Material Embedded Subcutaneously in Rats
11 Chapter 2 Tissue Reaction to Root Canal Filling Material Embedded Subcutaneously in Rats Takanaga Ochiai Keisuke Nakano Hiromasa Hasegawa Toshiyuki Kawakami Abstract The reaction of subcutaneous connective
More informationResults of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency
Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Ken-ichi ASANO, M.D., Masahiko WASHIO, M.D., and Shoji EGUCHI, M.D. SUMMARY (1) Surgical results of
More informationAortic stenosis is the most common acquired heart valve. The Toronto Root Bioprosthesis: Midterm Results in 186 Patients
The Toronto Root Bioprosthesis: Midterm Results in 186 Patients Sven Lehmann, MD, Thomas Walther, MD, PhD, Sergey Leontyev, MD, Jörg Kempfert, MD, Jens Garbade, MD, Michael A. Borger, MD, PhD, and Friedrich
More informationTAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?
TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular
More informationStentless aortic xenografts were introduced a decade
Survival After Stentless and Stented Xenograft Aortic Valve Replacement: A Concurrent, Controlled Trial Giovanni Battista Luciani, MD, Gianluca Casali, MD, Stefano Auriemma, MD, Francesco Santini, MD,
More informationPartial Aortic Valve Fusion Induced by Left Ventricular Assist Device
Partial Aortic Valve Fusion Induced by Left Ventricular Assist Device Alan G. Rose, MD, Soon J. Park, MD, Alan J. Bank, MD, and Leslie W. Miller, MD Department of Laboratory Medicine and Pathology, Division
More informationTreatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques
Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Pablo Codner, Abid Assali, Hanna Vaknin-Assa, Katia Orvin, Ram Sharony, Leor Perl, Gabriel Greenberg, Marina Kupershmidt,
More informationTechniques for repair of complete atrioventricular septal
No Ventricular Septal Defect Patch Atrioventricular Septal Defect Repair Carl L. Backer, MD *, Osama Eltayeb, MD *, Michael C. Mongé, MD *, and John M. Costello, MD For the past 10 years, our center has
More informationAORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM
AORTIC VALVE REPLACEMENT WITH FREEHAND AUTOLOGOUS PERICARDIUM Fifty-one patients with a mean age of 31.2 years underwent aortic valve replacement with glutaraldehyde-treated autologous pericardium. Pure
More informationIatrogenic pathology of the heart:
Iatrogenic pathology of the heart: Complications of mitral valve plasty and replacement Patrick Bruneval D pt of Pathology Hôpital Européen Georges Pompidou Enterprise Interest None Mitral valve surgery
More informationClinical material and methods. Copyright by ICR Publishers 2003
Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and
More informationLate Results with Autogenous
Late Results with Autogenous Tissue Heart Valves W. Sterling Edwards, M.D. ABSTRACT Five years of experience using unsupported and mounted fascia lata and pericardial heart valves in human beings is summarized.
More informationReplacement of the Ascending Aorta, Aortic Root and Valve with a Novel Stentless
Title: Replacement of the Ascending Aorta, Aortic Root and Valve with a Novel Stentless Valved-Conduit Running Head: Replacement of Ascending Aorta and Valve Authors: Kelvin K.W. Lau MRCS DPhil Krystyna
More informationHani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz
Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for
More informationSOLO SMART. The smart way to return to life. Native-like performance now with stented-like implantability
SOLO SMART TM The smart way to return to life Native-like performance now with stented-like implantability MANY PATIENTS NEED SUPERIOR HEMODYNAMIC PERFORMANCE TO RETURN TO THEIR NORMAL LIFESTYLE. 2 SOLO
More informationTAVI EN INSUFICIENCIA AORTICA
TAVI EN INSUFICIENCIA AORTICA Cesar Moris Profesor Cardiología Director Departamento del Corazón Hospital Universitario Central de Asturias Universidad de Oviedo OVIEDO -- ESPAÑA CONFLICTO DE INTERESES
More informationAppropriate Use of TAVR - now and in the future. A Surgeon s Perspective. Neil Moat Royal Brompton Hospital, London, UK
Appropriate Use of TAVR - now and in the future A Surgeon s Perspective Neil Moat Royal Brompton Hospital, London, UK Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner
More informationA tions in the United States annually [l]. Despite. Calcification of Porcine Valves: A Successful New Method of Antimineralization
Calcification of Porcine Valves: A Successful New Method of Antimineralization John Parker Gott, MD, Pan-Chih, MD, Lynne M. A. Dorsey, MBA, John L. Jay, MD, G. Kimble Jett, MD, Frederick J. Schoen, MD,
More information